“…ICSS is generally not affected or only depressed by systemically administered agonists and/or antagonists for 5HT 1 receptors (Harrison et al, 1999;Harrison and Markou, 2001), 5HT 2 receptors (Benaliouad et al, 2007;Hayes et al, 2009;Katsidoni et al, 2011), 5HT 3 receptors (Greenshaw, 1993;Hatcher et al, 1995), and 5HT 4 receptors (Reavill et al, 1998) (see Hayes and Greenshaw, 2011 for review). An exception is that low doses of the 5HT 1A agonist 8-OH-DPAT may facilitate ICSS (Harrison and Markou, 2001).…”